In lung cancer, IR has been shown to promote tumor cell invasion and migration through the upregulation of IL-1β and its receptor, interleukin-1 receptor type I (IL-1RI) or II (IL-1RII) (27). This evidence concerns the gene IL1B and neoplasm.